Carbonic Anhydrase-8 (CA8*) Gene Therapy(Adolore BioTherapeutics)

N/A

Report date: 2023/12/06 16:55:24

Base Information

Drug NameCarbonic Anhydrase-8 (CA8*) Gene Therapy(Adolore BioTherapeutics)
Drug Alias NameCarbonic Anhydrase-Like Analgesic Peptides, CA8 VariantsrdHSV-CA8
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy
Mechanisms of ActionCarbonic anhydrase-related protein gene transference
TargetsCarbonic anhydrase-related protein
Therapy Area/IndicationsPainNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAdolore Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAdolore Biotherapeutics Inc
Inactive CompaniesN/A
Active IndicationsPainNeuralgia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A